Clinical Trials Browser

Phase 2 × OTHER × 26S proteasome non-ATPase regulatory subunit 13 × Clear all

NCT07463677 2026-03-11

Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03185988 2019-07-19

Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Biliary Tract Neoplasms, Colorectal Neoplasms